Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
Clinical trial NCT01452139 · COMPLETED
Trial details
- NCT number
- NCT01452139
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.